Likewise, TP53 mutations, which disrupt the G1/S checkpoint, enforce dependency on the G2/M checkpoint and sensitize cancer cells to Wee1 and Chk1 inhibition [127,166]. This evidence concerns the gene CHEK1 and cancer.